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Kunihiro Ishioka, MD, Hidekazu Moriya, MD, Sumi Hidaka, MD, PhD, and
Shuzo Kobayashi, MD, PhD, Kamakura, Japan
Background: Peripheral arterial disease (PAD) is one of the serious complications in patients on hemodialysis (HD)
therapy. However, arterial calcification of lower limbs’ arteries and its impact on the prevalence and severity of PAD has
never been quantitatively evaluated in HD patients with PAD.
Methods:Ninety-seven HD patients were enrolled to evaluate calcification score in superficial femoral artery (SFACS) and
below-knee arteries (BKACS) quantitatively by 64-row multidetector computed tomography as well as ankle-brachial
pressure index (ABI), toe-brachial pressure index (TBI), and clinical and laboratory parameters.
Results: Forty-six patients (47.2%) had PAD, and 11 patients had critical limb ischemia (CLI). SFACS and BKACS were
significantly associated with the prevalence and severity of PAD, and receiver-operating characteristic analysis showed
that SFACS and BKACS well predicted the prevalence of PAD and CLI in HD patients. The independent associating
factors for PAD were BKACS and low TBI (r2 0.534; P< .0001). Low TBI was also an independent associating factor
for CLI (r2  0.245; P < .0001). Multivariate analysis indicated that the independent associating factors for TBI in HD
patients were BKACS and C-reactive protein (CRP; r2  0.358; P  .006).
Conclusions: Present quantitative analysis clearly provided the first evidence that arterial calcification of lower limbs’
arteries was closely associated with the prevalence and severity of PAD in HD patients. Furthermore, arterial calcification
of below-knee arteries andmicro-inflammation represented as CRPwere the independent associating factors for low TBI,
which was the independent associating factor for PAD and CLI in HD patients. ( J Vasc Surg 2011;53:676-83.)
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hPeripheral arterial disease (PAD) is common1,2 and has
much impact on mortality in patients on hemodialysis (HD).3
Once patients undergo a major amputation in their lower limb
due to PAD, the 1-year survival rate falls to almost 50%,4 and
it is almost comparable to the 1-year survival rate after acute
myocardial infarction in HD patients.5 Therefore, it is very
important to detect PAD in its early phase and start to treat
PAD by first-line basic treatment including walking exercise,
cessation of smoking, and medication, including cilostazol,6,7
as soon as possible in HD patients.
Measurement of ankle-brachial pressure index (ABI) is
widely used for the screening of PAD. However, the value of
ABI should be carefully interpreted in cases with advanced
arterial calcification. Arterial calcification of the lower extrem-
ity significantly affects the ABI value.8 Accurate ABI values
may not be obtained in cases of high arterial calcification or
incompressible arteries. Therefore, arterial calcification may
lead to misunderstanding the ABI value to be pseudo-normal
when the arterial calcification of the lower limb is prominent.
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676urthermore, arterial calcification often makes it difficult to
evascularize the target arteries in HD patients by percutane-
us peripheral intervention or bypass surgery. Thus, arterial
alcification may strongly influence the diagnostic evaluation
nd/or therapy for HD patients with PAD. However, the
revalence, severity, and the impact of arterial calcification on
AD in HD patients have never been evaluated.
Arterial calcification of lower limbs may be cross-
ssociated with PAD in HD patients and provide better pre-
ictive value for PAD and critical limb ischemia (CLI) than
BI and toe-brachial pressure index (TBI). Therefore, our
urpose in this study was to evaluate 1) the arterial calcifica-
ion score (CS) of the arteries of the lower limb quantitatively
y multidetector-row computed tomography (MDCT), and
) the relationship between CS and the severity of PAD in HD
atients. We also evaluated the associating factors for PAD
nd CLI and compared the predictive power of CS with ABI
nd TBI for PAD and CLI in HD patients.
ETHODS
Patients. The potential subjects comprised all 140
utpatients who had been undergoing HD therapy during
ctober 2008 in the dialysis center in our hospital. Patients
ith age over 85 years (13 patients) before study entry were
xcluded. Patients with involuntary movement of lower
imbs (11 patients) were also excluded because they could
ot be examined by MDCT. Among the remaining 116
utpatients, 97 patients gave consent to undergo nonen-
anced MDCT for evaluating CS of the arteries of theower limbs, and all these patients finally entered the study.
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Volume 53, Number 3 Ohtake et al 677MDCT in artery of lower limb. Patients underwent
noncontrast-enhanced MDCT scanning of the lower limb’s
arteries using a 64-row MDCT scanner (SOMATOM Sen-
sation Cardiac 64; Siemens AG, Munich, Germany). Scans
were performed using a 3-mm-increment, mAs 200, and
kV  120 with a field of view of 350 to 380 mm, yielding
typical special resolution 0.7  0.7  3.0 mm3 as previ-
ously reported.9 The scan duration of the lower limb was
approximately 12 to 15 seconds. From the acquired raw
data, the scan was reconstructed in 3-mm slices. The aver-
age number of slices of lower extremities was approximately
350.
Arterial calcification scoring of the lower limb. The
scoring of calcification for bilateral superficial femoral arter-
ies (SFA) and below-knee arteries (BKA) including anterior
tibial, posterior tibial, and peroneal arteries was performed
using standardized calcium scoring software (Aquarius Net
Station, Terarecon, Foster City, Calif) by investigators who
were blinded to the results of the patients’ clinical assess-
ment and Fontaine’s severity categories. On cross-sectional
images through the lower extremities, area of calcification
with a cross-sectional area 1 mm and a density of 130
Hounsfield units were identified automatically. Measure-
ments were started at the divergence of the SFA and the
deep femoral artery and ended at the widest portion of the
tibial and fibular malleoli at the ankle. CS for each area of
interest along the course of the SFA and below-knee artery
calcification score (BKACS) was determined and ex-
pressed as Agatston score according to the method de-
scribed by Agatston et al.10
Measurement of ABI and TBI. To evaluate the func-
tional blood flow in the lower extremities, we conducted
physiological measurements including ABI and TBI. ABI
and TBI were measured as previously reported using Form
ABI (Nippon Colin, Komaki, Japan).1 The instrument
simultaneously records the blood pressure in the four ex-
tremities. For measurement of ABI and TBI, room temper-
ature was constantly kept at 25°C, and one well-trained
examiner performed ABI and TBI measurements for all
patients after 5 minutes bed rest. The toe was cleaned by a
warmed wet towel before TBI measurement, and the cuff
was encircled around the toe according to the manufactur-
er’s recommendation. ABI and TBI were calculated as the
ratio of ankle and toe to brachial systolic blood pressure,
respectively. Normal values of ABI and TBI were reported
to be 0.9 to 1.3 and 0.6 , respectively.11 Therefore, the
cut-off value of ABI and TBI for diagnosing PAD were set
at 0.9 and 0.6, respectively.
Patient assessment and group assignment. Patients
were asked about symptoms of PAD including chillness,
numbness, ischemic claudication, and resting pain. Previ-
ous histories of intervention (percutaneous peripheral in-
tervention or bypass surgery) or amputation for PAD were
also registered. All patients then underwent physiological
examination about skin color, warmth, pulse exam of fem-
oral artery, popliteal artery, dorsal artery, posterior tibial
artery, and skin lesions, including ulcers and gangrene. This
symptomatic information, previous histories of interven- dion or amputation, and physiological examinations includ-
ng ABI and TBI were basically used to assign a limb
schemia according to the PAD severity classification crite-
ia set by Fontaine et al.12 When patients fulfilled any
schemic symptoms with at least one abnormality among
BI 0.9, TBI 0.6, or had apparent previous history of
ntervention or amputation of lower limbs, they were de-
ned as having PAD. In cases with clinical symptoms
ncluding chilliness or numbness without ABI 0.9 nor
BI 0.6, skin perfusion pressure (SPP) was measured.
PP was measured using Laser Doppler (PAD 3000;
aneka Corporation, Osaka, Japan). The PAD 3000 auto-
atically measures SPP using the laser Doppler transmitter
nd detector, which were set with a pressure cuff. Two
oints were set for measurement in each patient: 1) a point
etween the first and second metatarsal bones in the instep
nd 2) a front middle point in the sole. After inflating the
uff pressure at first to stop skin perfusion, the cuff pressure
as deflated and the point of cuff pressure measured when
kin perfusion was restarted. SPP was expressed as this
ressure of restarting the skin perfusion. If the SPP value
as 50 mm Hg, the patient was thought to have PAD
ontaine I. Classification of Fontaine stage was confirmed
y three doctors using the data files about ABI, TBI, and
PP findings along with their clinical symptoms. The clas-
ification to Fontaine was not done in a blinded manner.
Clinical and laboratory parameters. Clinical infor-
ation was collected by medical records about age, gender,
ialysis duration, cause of renal failure, hyperlipidemia,
ypertension, diabetes mellitus (DM), and comorbid dis-
ases including ischemic heart disease (IHD) and stroke.
aboratory parameters including serum albumin, calcium
Ca), inorganic phosphate (Pi), CRP, total cholesterol,
riglycerides (TG), high-density lipoprotein (HDL) choles-
erol, low-density lipoprotein (LDL) cholesterol, and
lasma fibrinogen were measured using blood samples at
he start of first HD of the week within 2 weeks from
DCT. Levels of serum Ca were registered after correcting
ith albumin and used for calculation of Ca  Pi product.
rug use about vitamin D and phosphate binder calcium
arbonate were also registered.
Statistical analysis. All data are presented as the
ean SD. Skewed variables including CRP, SFACS, and
KACS underwent log transformation if necessary before
tatistical analysis. Data of the dominant side of the leg for
AD in each patient were selected and used for analysis for
BI, TBI, SFACS, and BKACS. Comparison of group
ean values was done with the two-tailed unpaired Stu-
ent’s t test. Categorical variables were compared using the
2 test and Fisher’s test. Univariate analysis between CS
nd several parameters was done using Spearman rank
orrelation coefficient. Stepwise logistic regression analysis
as performed based on a forward-backward procedure to
efine the independent variables related to CS. The F value
or entry or removal of candidate variables from the discrim-
nant function was set at 4.0. Dummy variables were used
or gender (male 1, female 0), DM (yes 1, no 0),
rug use (yes  1, no  0), PAD (yes  1, no  0), and
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(ROC) analysis was performed to evaluate the predicting
power, sensitivity, and specificity of ABI, TBI, SFACS, and
BKACS for PAD and CLI in HD patients. Stat View 5.0
software for Windows (SAS Institute, Cary, NC) and SPSS
statistics version 11.0 (SPSS Inc, Chicago, Ill) were used for
data analysis on a personal computer, and P  .05 was
considered significant.
RESULTS
Patients. The mean age and HD duration of all sub-
jects were 67.8  12.2 years (range, 33-84 years) and
71.9  79.0 months (range, 1-442 months), respectively.
Almost 40% of the patients had diabetes mellitus. Ischemic
heart disease and stroke were shown in 30.9% and 15.4% of
all patients, respectively. One patient had a previous history
of above-knee amputation of one leg, and another one
Table I. Stratified data according to Fontaine’s classificatio
PAD ()
(n  51)
Age (yr) 63.6  13.3
Male/female (n) 34:17
HD duration (months) 54.7  58.2
Risk factors n, (%)
Diabetes 13 (25.5)
Hypertension 47 (92.1)
Hyperlipidemia 6 (11.8)
Smoking 9 (17.6)
Comorbidity n, (%)
IHD 5 (9.8)
Stroke 2 (3.9)
Blood pressure (mm Hg)
Systolic 139.4  19.7 1
Diastolic 80.0  12.8
Laboratory valuables
Ca (mg/dL) 9.0  0.6
Pi (mg/dL) 5.6  1.5
Ca  Pi (mg2/dL2) 50.5  13.7
Albumin (g/dL) 3.7  0.5
Fibrinogen (mg/dL) 325.6  89.7 3
CRP 0.24  0.41
T. Chol (mg/dL) 164.7  45.6 1
TG (mg/dL) 92.7  44.1 1
HDL-C (mg/dL) 49.8  17.4
LDL-C (mg/dL) 84.0  34.0
Drug usage n, (%)
ARB 40 (78.4)
ACE-I 4 (7.8)
Statin 6 (11.8)
Phosphate binder
Calcium carbonate 36 (51.0)
Sevelamer 10 (19.6)
Vitamin D 26 (50.9)
ACE-I, Angiotensin-converting enzyme inhibitor; ARB, angiotensin recep
HDL-C, high-density lipoprotein cholesterol; IHD, ischemic heart disease; L
TG, triglyceride; PAD, peripheral arterial disease.
Data are expressed as mean  SD.
aP  .05 vs PAD ().
bP  .01 vs PAD ().patient had a history of below-knee amputation of one leg. finor amputations were shown in other three patients
two with toe, one with little toe). Mean levels of serum Ca,
i, and Ca Pi product were 9.1 0.8 mg/dL, 5.5 1.5
g/dL, and 50.6  14.2 mg2/dL2, respectively. Calcium
arbonate was used in 65% of the patients. Mean levels of
BI and TBI of all subjects were 1.12  0.23 and 0.67 
.31, respectively. Mean levels of SFACS and BKACS were
873.8  4331.6 and 2258.0  4328.4, respectively.
Associations between PAD and clinical and labora-
ory parameters. Table I shows stratified patients’ charac-
eristics according to the Fontaine classification. PAD was
hown in 46 patients (47.2%) according to the patients’
ssessment and Fontaine’s classification. Twenty-seven,
ight, and 11 patients were classified as having PAD of
ontaine stage I, II, and IV, respectively. There was no
atient with Fontaine stage III in our subjects. Patients
ith PAD (stage I, II, and IV) had significantly higher
PAD ()
Fontaine classification
27) II (n  8) IV (n  11)
 8 71.4  6.6 73.1  10.5a
:13 8:0 7:4
 72.8 171.1  144.7 74.9  70.8
4.5) 4 (50.0) 9 (81.8)b
00) 8 (100) 11 (100)
5.9) 0 (0) 5 (45.5)a
1.1) 1 (12.5) 1 (9.0)
5.6)b 4 (50.0)a 6 (54.5)b
2.2)a 3 (37.5)a 4 (36.3)a
 21.1 128.2  18.9 136.7  20.6
 12.1 68.9  8.8 72.6  12.8
 0.6 9.2  1.1 9.2  0.9
 1.4 4.9  1.2 6.0  2.0
 13.1 44.6  10.4 54.8  20.3
 0.4 3.6  0.2 3.3  0.4a
 88.6 312.2  84.8 424.5  91.5b
 0.46 0.70  1.43a 6.91  16.5b
 39.1 136.8  20.1 144.0  35.1
 88.1 104.1  41.3 89.8  27.6
 14.3 39.4  11.9 44.8  12.8
 25.9 65.9  17.7 74.4  32.3
1.9) 5 (62.5) 4 (36.3)a
7.0) 0 (0) 0 (0)
5.9) 0 (0) 5 (45.5)a
9.3) 5 (62.5) 6 (54.5)
9.6) 6 (75.0)b 3 (27.3)
2.9) 5 (62.5) 7 (63.6)
pe II blocker; Ca, calcium; CRP, C-reactive protein; HD, hemodialysis;
, low-density lipoprotein cholesterol; Pi, phosphate; TCho, total cholesterol;n
I (n 
72.7
14
73.9
12 (4
27 (1
7 (2
3 (1
15 (5
6 (2
42.3
75.3
9.2
5.5
50.7
3.7
19.1
0.35
66.0
10.2
47.2
79.5
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7 (2
16 (5
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Volume 53, Number 3 Ohtake et al 679stroke, than those without PAD. IHD was shown almost
about 50% or more in patients with any stage of PAD.
Patients with Fontaine IV PAD showed significantly older
age, higher frequency of diabetes, lower levels of serum
albumin, and higher levels of CRP and fibrinogen than
those without PAD. Serum cholesterol including total cho-
lesterol, HDL cholesterol, and LDL cholesterol showed
lower levels among patients with advanced stages of PAD
than those without PAD, although this was not statistically
significant. Serum levels of Ca, Pi, and Ca  Pi were not
different between patients with and without PAD. Use of
calcium carbonate and vitamin D also showed no difference
between patients with and without PAD.
Association between PAD and CS/ABI/TBI.
Although clinical and laboratory parameters showed no
significant difference except for frequency of other vascular
complications between patients with Fontaine I PAD and
those without PAD, all physiological parameters, including
ABI, TBI, and calcification scores of SFA and BKA, showed
significant differences between patients with Fontaine I
(earliest stage of PAD) and those without PAD (Fig 1,
Table II). The most significant differences between patients
with Fontaine I and those without PAD were shown in
SFACS and BKACS. Thus, PAD in HD patients, even if
they were in the early stage of PAD, was accompanied by
severe arterial calcification (Fig 1).
Associating factor for CS in HD patients. Table III
shows the associating factors for CS in HD patients in
univariate and multivariate analysis. The common indepen-
dent associating factors for both SFACS and BKACS were
age, HD duration, DM, and IHD by multivariate analysis.
Serum Ca was also an independent associating factor for
BKACS, while log CRP was an independent associating
factor for SFACS.
Association of CS and ABI/TBI. SFACS, BKACS,
ABI, and TBI significantly correlated with each other (Ta-
ble IV). SFACS and BKACS showed good correlation (r
0.797; P  .0001). As for ABI, SFACS had stronger
negative correlation with ABI (r  0.493; P  .0001)
than BKACS (r  0.404; P  .0001). TBI had almost
equal correlation with SFACS (r  0.488; P  .0001)
and BKACS (r  0.478; P  .0001), respectively.
Association between the severity of PAD and
CS/ABI/TBI. Among patients with PAD, although the
mean levels of ABI did not show the significant decrease
along with the progression of Fontaine stage, levels of TBI,
SFACS, and BKACS, each showed significant changes
along with the progression of PAD stage (P  .001 be-
tween Fontaine I and IV; Table II). Multivariate analysis
revealed that the independent associating factors were
BKACS and low ABI and TBI value for PAD (r2  0.534;
P .0001) and low TBI value and fibrinogen for CLI (r2
0.245; P  .0001), respectively (Table V).
Predictive values of CS/ABI/TBI for PAD and
CLI. Predictive values of ABI, TBI, and calcification score
for PAD and CLI were analyzed using ROC analysis and
shown in Fig 2, Table VI. Area under the curve (AUC) of
ABI and TBI for detecting PAD was 0.908 and 0.875, despectively (Fig 2). If the cut-off value of ABI was set at
1.06, the sensitivity and specificity for detecting PAD in
D patients were 80.0% and 98.0%, respectively (Table
I). SFACS and BKACS also had AUC over 0.80 for
redicting PAD (Fig 2). As for CLI, SFACS and BKACS
lso had AUC levels over 0.85 (Fig 2) and could detect CLI
n HD patients with high sensitivity and specificity over 70%
Table VI), respectively.
Associating factors for low TBI in HD patients.
ecause low TBI was an independent associating factor for
oth PAD and CLI in HD patients, we then evaluated the
ssociating factors for TBI in HD patients. As shown in
able VII, several clinical and laboratory parameters in-
luding BKACS, SFACS, CRP, diabetes, and age were
ignificantly correlated with TBI in univariate analysis.
ultivariate analysis using these variables as independent
ariables revealed that BKACS and CRP were the indepen-
ig 1. Calcification score of SFA (A) and BKA (B) in HD pa-
ients with and without peripheral arterial disease. *P  .001 vs
AD (); #P .001 vs Fontaine I.BKA,Below-knee arteries;HD,
emodialysis; SFA, superficial femoral artery.ent associating factors for low TBI.
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Our present study clearly provided the evidence that 1)
PAD was shown in high frequency in prevalent HD patients
and 2) patients with advanced stage of PAD were correlated
with hypoalbuminuria, inflammation, and high frequency
Table II. ABI/TBI and CS according to Fontaine’s classi
PAD ()
(n  51) I (n  2
ABI 1.21  0.09 0.92  0.
TBI 0.78  0.22 0.50  0.
SFACS 1910.4  6122.6 4183.3  38
BKACS 634.3  1387.5 2222.7  31
ABI, Ankle-brachial pressure index; BKA, below-knee arteries; CS, calcifica
toe-brachial pressure index.
aP  .01 vs PAD ().
bP  .001 vs PAD ().
cP  .001 vs Fontaine I.
dP  .01 vs Fontaine II.
Table III. Univariate and multivariate analysis for CS in
SFA and BKA in HD patients
Variable
Univariate analysis
Multivariate regression
analysis
r P
Standard
coefficient P
SFACS
Age 0.449 .0001 0.333 .0003
HD duration 0.268 .008 0.327 .0001
DM — .0002 0.308 .0004
IHD — .0001 0.229 .009
Stroke — .032
Total
cholesterol
0.324 .001
LDL
cholesterol
0.337 .0007
log CRP 0.304 .002 0.163 .046
R2  0.549,
P  .0001
BKACS
Age 0.327 .001 0.285 .0024
HD duration 0.337 .0007 0.392 .0001
DM — .0002 0.371 .0001
IHD — .0001 0.330 .0003
Stroke — .02
Serum calcium 0.281 .005 0.331 .0005
Total
cholesterol
0.268 .007
LDL
cholesterol
0.250 .013
log CRP 0.336 .0007
R2  0.610,
P  .0001
BKACS, Below-knee arteries calcification score; CRP, C-reactive protein;
CS, calcification score; DM, diabetes mellitus; HD, hemodialysis; IHD,
ischemic heart disease; LDL, low-density lipoprotein; SFACS, superficial
femoral artery calcification score.of vascular complications including IHD and stroke. Fur- ahermore, we provided the first evidence that 1) vascular
alcifications of SFA and BKA were closely associated with
he prevalence and severity of PAD in HD patients, 2) low
BI was the independent associating factor for both PAD
nd CLI, and 3) the independent associating factors for low
BI were BKACS and CRP. We primarily hypothesized
hat SFACS or BKACS might have better predictive power
or PAD and CLI than ABI and TBI. Indeed, SFACS and
KACS correlated well with the prevalence and severity of
AD. However, ABI and TBI were still as good as SFACS
r BKACS in identifying PAD or CLI in HD patients.
Vascular calcification both in the SFA and BKA had
on
PAD ()
Fontaine classification
II (n  8) IV (n  11)
0.82  0.27 0.82  0.26
0.49  0.21 0.16  0.13c,d
b 4680.3  4682.7 9579.7  5856.9c
b 7151.1  7438.7 7565.9  5808.0c
core; PAD, peripheral arterial disease; SFA, superficial femoral artery; TBI,
able IV. Correlation between CS and ABI/TBI
r P
og SFACS and log BKACS 0.797 .0001
og SFACS and ABI 0.493 .0001
og SFACS and TBI 0.488 .0001
og BKACS and ABI 0.404 .0001
og BKACS and TBI 0.478 .0001
BI, Ankle-brachial pressure index; BKACS, below-knee arteries calcifica-
ion score; CS, calcification score; SFACS, superficial femoral artery calcifi-
ation score; TBI, toe-brachial pressure index.
able V. Independent associating factors for PAD and
LI in HD patients
ultivariate analysis Standard regression coefficient
AD
BI 0.414
og BKACS 0.276
BI 0.248
r2  0.534; P  .0001
LI
BI 0.401
ibrinogen 0.217
r2  0.245; P  .0001
BI, Ankle-brachial pressure index; BKACS, below-knee arterial calcifica-
ion score; CLI, critical limb ischemia; HD, hemodialysis; PAD, peripheral
rterial disease; TBI, toe-brachial pressure index.ficati
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Volume 53, Number 3 Ohtake et al 681HD patients. Therefore, vascular calcification of the lower
limbs may be directly associated with the onset of PAD in
HD patients. Vascular calcification has been reported to
progress before the initiation of HD. Coronary artery
calcification significantly progressed if the patients’ esti-
mated glomerular filtration ratio falls below 60 mL/
min/1.73m2.13 As for PAD in patients with chronic
kidney disease without renal replacement therapy,
O’Hare et al14 and de Vinuesa et al15 reported that 24%
Fig 2. Receiver-operating characteristic (ROC) analys
SFACS/BKACS on PAD and CLI. ROC curves for the p
(A-2) for PAD, ABI, and TBI (B-1) and SFACS and BKA
area under the curve;BKACS, below-knee artery calcificat
disease; SFACS, superficial femoral artery calcification scand 32% of patients with creatinine clearance 60 mL/ lin/1.73m2 had ABI values below 0.9, respectively.
urthermore, Leskinen et al8 reported a high prevalence
23.7%) of medial arterial calcification in lower extremities in
atients with predialysis renal failure (creatinine levels: 3.6 
.5 mg/dL). Vascular calcification further progresses along
ith the HD duration after patients started HD therapy,
ecause HD duration was shown to be the independent
ssociating factor for SFACS and BKACS.
As to CLI, the independent associating factors were
OC curves for the predictive value of ABI/TBI and
ive value of ABI and TBI (A-1) and SFACS and BKACS
-2) for CLI. ABI, Ankle-brachial pressure index; AUC,
ore;CLI, critical limb ischemia; PAD, peripheral arterial
BI, toe-brachial pressure index.is. R
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CS (B
ion scow TBI and fibrinogen. Furthermore, the independent
b
p
a
p
w
b
s
t
H
d
v
l
p
m
v
t
r
c
s
H
a
s
F
(
o
a
w
n
v
d
t
A
d
p
a
t
p
r
c
v
t
t
B
a
S
A
i
g
m
r
W
c
p
JOURNAL OF VASCULAR SURGERY
March 2011682 Ohtake et alassociating factors for low TBI were BKACS and CRP.
Fibrinogen is known to be associated with blood viscosity
and inflammation. Although we did not examine blood
viscosity in our subjects, fibrinogen was well correlated with
CRP in our study (r 0.567; P .01). Therefore, vascular
calcification of BKA and inflammation represented as CRP
and fibrinogen may be the major associating factors for CLI
in HD patients. About the relationship between BKACS
and CLI in the general population, Guzman et al reported
an important finding of an increased amputation risk in 118
PAD patients with high tibial artery calcification score.9
The cut-off value for predicting future amputation in tibial
arteries was 400 in their study. However, they excluded
patients with serum creatinine levels 1.7 mg/dL. There-
fore, our study is the first report that provided the quanti-
tatively evaluated calcification score in HD patients with or
without PAD. Although Guzman et al evaluated only tibial
artery calcification score as a culprit for risk factor in future
amputation, we evaluated the sum score in BKA. Amputa-
Table VI. Cut-off value, sensitivity, and specificity of
ABI, TBI, SFACS, BKACS for detecting PAD and CLI in
HD patients
Cut-off value Sensitivity Specificity
PAD total
ABI 1.06 80.0% 98.0%
TBI 0.6 82.5% 86.0%
SFACS 1600 71.7% 88.2%
BKACS 140 87.0% 62.7%
CLI
ABI 1.0 88.9% 72.8%
TBI 0.25 77.8% 88.9%
SFACS 2440 100% 74.1%
BKACS 780 91.7% 74.3%
ABI, Ankle-brachial pressure index; AUC, area under the curve; BKACS,
below-knee arteries calcification score; CLI, critical limb ischemia (Fontaine
III, IV); CS, calcification score; PAD, peripheral arterial disease; ROC,
receiver-operating characteristic; SFACS, superficial femoral artery calcifica-
tion score; TBI, toe-brachial pressure index.
Table VII. Associating factors for TBI in HD patients
Univariate analysis R P
log BKACS 0.488 .001
log CRP 0.443 .001
log SFACS 0.430 .001
Diabetes 0.401 .001
Age 0.308 .003
Fibrinogen 0.238 .023
Multivariate analysis Standard regression coefficient
log BKACS 0.298
log CRP 0.286
r2  0.358; P  .006
BKACS, Below-knee arteries calcification score; CRP, C-reactive protein;
HD, hemodialysis; SFACS, superficial femoral artery calcification score; TBI,
toe-brachial pressure index.tion of the lower limb due to severe ischemia may be related iy one or more vessel diseases including anterior tibial,
osterior tibial, and peroneal arteries. The damaged target
rteries relevant to amputation may differ from patient to
atient. Furthermore, except for acute ischemia, patients
ith chronic limb ischemia usually show the collateral
lood flow from less-damaged vessels to the ischemic le-
ion. Therefore, we selected the sum of calcification in BKA
o know the total degree of below-knee arterial damage in
D patients.
ABI and TBI values are generally used as a tool for
etecting PAD in the general population. However, ABI
alues may be influenced by vascular calcification and may
ead to misunderstanding of PAD in HD patients.1,8 In our
resent study, the cut-off value of ABI for detecting PAD
ay be set at 1.06 in case of HD patients. In this cut-off
alue, we can detect PAD in HD patients with high sensi-
ivity and specificity of 80.0% and 98.0%, respectively. This
esult further strengthens our previous report1 that the
ut-off value of ABI for PAD in HD patients might be
hifted to 1.1.
ABI may be a useful measure for detecting PAD also in
D patients. However, it did not correlate with the severity
mong the HD patients with PAD. The mean ABI did not
how a significant difference between HD patients with
ontaine I and IV, while TBI and vascular calcification
SFA and BKA) were well correlated with the progression
f PAD. In patients with noncalcified vessels, ABI often
dequately indicates the severity of the ischemia. It is also
ell established that the test is not adequate in patients with
oncompressible vessels. Because noncompressible ABI
alues were included as straight ABI value, this might
iminish the predictive value of ABI for PAD and CLI in
his study. ABI indicates the presence of PAD. However,
BI alone should not be used to assess the severity of the
isease. In consideration of the decrease of TBI with un-
aralleled ABI along with the progression of PAD, below-
nkle peripheral vascular disease may be very important for
he progression of PAD from its early stage to CLI in HD
atients.
SFACS, BKACS, ABI, and TBI were significantly cor-
elated with each other. SFACS and BKACS had a strong
orrelation (r  0.797; P  .0001). In evaluating the ABI
alue, SFACS had a stronger negative correlation with ABI
han BKACS. Therefore, although the ABI value is usually
hought to be elevated by noncompressible highly-calcified
KA, highly-calcified SFA might further strongly influence
nd lower the ABI value if the patient had highly-calcified
FA and BKA. We should be very careful to evaluate the
BI value in patients with highly-calcified arteries.
In the case of the coronary artery, vascular calcification
s reported to be associated with older age and DM16 in the
eneral population. In case of HD patients, mineral abnor-
alities including Ca, Pi, and Ca  Pi product17,18 is also
eported to be associated with coronary artery calcification.
e recently reported that micro-inflammation was signifi-
antly associated with coronary artery calcification and its
rogression.19 Micro-inflammation was identified as an
ndependent associating factor for progression of coronary
11
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represented as CRP was also the independent associating
factor for SFACS.
Common independent associating factors for both
SFACS and BKACS were age, HD duration, DM, and
IHD. Amputation risk in diabetic HD patients is reported
to be very high compared with those without DM.20,21
Amputation of a lower limb in diabetic HD patients may
mainly be attributed to diabetic gangrene. However, DM
strongly affected vascular calcification of lower limbs in HD
patients. Vascular calcification, especially in BKACS, is
strongly associated with low TBI. Therefore, our findings
may explain the reason why diabetic patients on HD have a
significant high risk of PAD and amputation.
In conclusion, although the number of patients in this
study is rather small and this is a single-center study, we
provided the first evidence that quantitatively evaluated
vascular calcification of the arteries of lower limbs (SFACS
and BKACS) was closely associated with the prevalence and
severity of PAD in HD patients. Calcification of BKA and
micro-inflammation were the important key factors for low
TBI relevant to PAD and CLI in HD patients. Further
studies are necessary to clarify the clinical importance of the
arterial calcification of lower limbs in HD patients, who are
at high risk of PAD and CLI. The association of the arterial
calcification of lower limbs with luminal narrowing, rate of
technical success in revascularization, and future amputa-
tion risk needs to be clarified in the future.
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